Thursday, 18 August 2022

Bavarian Nordic signs up U.S. firm for packaging monkeypox vaccine

Bavarian Nordic signs up U.S. firm for packaging monkeypox vaccine

Danish biotech firm Bavarian Nordic said on Thursday it has signed up a U.S.-based manufacturer to package its Jynneos monkeypox vaccine and the production is expected to begin later this year.

John Hancock in $26.3 mln settlement with New York over canceled insurance policies

John Hancock Life & Health Insurance Co will pay $26.3 million to settle a New York probe that found it prematurely terminated long-term care policies before policyholders, many now dead, exhausted their benefits.

Bluebird falls on worries over $2.8 mln gene therapy's commercial success

Bluebird bio slumped nearly 15% on Thursday as investors fretted over sales potential of its newly approved ultra-rare blood disorder gene therapy that is the most expensive treatment to date at $2.8 million.

U.S. to boost monkeypox vaccine supply with 1.8 million extra doses

The United States said on Thursday it will boost its supply of monkeypox vaccine by making available an extra 1.8 million doses of Bavarian Nordic's Jynneos shot, as the number of reported cases in the country rose above 13,500.

WHO recommends Valneva's COVID vaccine

The World Health Organization (WHO) on Thursday recommended the use of French drugmaker Valneva's COVID-19 vaccine.

Germany's constitutional court upholds measles vaccine mandate for children

The German constitutional court upheld the country's measles vaccine mandate for children on Thursday, ruling against a challenge brought by parents.

Valneva: U.S. Dept of Defense ends Ixiaro vaccine supply deal

The U.S. Department of Defense (DoD) has ended an encephalitis vaccine supply contract with Valneva , said the French drugmaker, adding that a slowdown in global travel activity, mainly affecting Asia, had led to lower demand.

Bluebird's $2.8 million gene therapy becomes most expensive drug after U.S. approval

The U.S. Food and Drug Administration on Wednesday approved bluebird bio's gene therapy for patients with a rare disorder requiring regular blood transfusions, and the drugmaker priced it at a record $2.8 million.

U.S. judge reinstates North Carolina ban on late-term abortions

A federal judge on Wednesday reinstated a decades-old North Carolina ban on abortions performed after 20 weeks of gestation, citing the U.S. Supreme Court's recent decision allowing states to freely regulate procedures to terminate pregnancy.

Incredible Health valued at $1.65 billion after latest fundraise

Incredible Health, a job platform for nurses, said on Wednesday it was valued at $1.65 billion after a fundraising round with participation from venture capital giant Andreessen Horowitz.

Related Videos

Why has polio returned to the United States?

Mobile fridges keep vaccines cool in Kenya

Mobile fridges keep vaccines cool in Kenya